Skip to content
drillr.ai
Sign up

TPST

Tempest Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.03
−1.90%
Ask drillr
1
Insider buys (3m)
0
Insider sells (3m)
$500.0K
Net value (3m)
-19.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 23, 2026Angel Matthew · director, 10 percent owner, officer: CEO and PresidentPurchase231,482$2.16
Jun 17, 2026Yee John D. · directorA-Award25,000$1.27
Jun 8, 2026Richey William Drake · directorA-Award25,000$1.27
Apr 2, 2026Trojanowski Justin · officer: Corporate ControllerA-Award22,000$1.64
Apr 2, 2026Maestas Nicholas · officer: Chief Financial OfficerA-Award140,000$1.64
Mar 25, 2026Angel Matthew · director, 10 percent owner, officer: CEO and PresidentPurchase231,482$2.16
Feb 6, 2026Angel Matthew · director, 10 percent owner, officer: CEO and PresidentA-Award269,621$2.38
Jan 28, 2026Simantov Ronit · directorA-Award1,230$2.94
Jan 28, 2026NICHOL GEOFFREY · directorA-Award1,230$2.94
Jan 28, 2026Pellizzari Christine A · directorA-Award1,230$2.94
Jan 28, 2026RAAB MICHAEL · directorA-Award1,230$2.94
Jan 6, 2025Maestas Nicholas · officer: Chief Financial OfficerA-Award200,000$0.86
Jan 6, 2025Whiting Samuel · officer: Chief Medical OfficerA-Award270,000$0.86
Jan 6, 2025Trojanowski Justin · officer: Corporate ControllerA-Award30,000$0.86
Jan 6, 2025Brady Stephen R · director, officer: President and CEOA-Award550,000$0.86
Aug 12, 2024Versant Venture Capital VI, L.P. · 10 percent ownerSale400,000$1.35
Aug 12, 2024Versant Venture Capital VI, L.P. · 10 percent ownerSale387,999$1.10
Jul 8, 2024Brady Stephen R · director, officer: President and CEOPurchase35,000$2.11
Jul 3, 2024Whiting Samuel · officer: Chief Medical OfficerPurchase4,672$2.13
Jul 2, 2024Trojanowski Justin · officer: Corporate ControllerPurchase7,500$2.16
Jun 14, 2024Pellizzari Christine A · directorA-Award16,000$3.03
Jun 14, 2024Simantov Ronit · directorA-Award16,000$3.03
Jun 14, 2024RAAB MICHAEL · directorA-Award16,000$3.03
Jun 14, 2024NICHOL GEOFFREY · directorA-Award16,000$3.03
Jan 5, 2024Whiting Samuel · officer: Chief Medical OfficerA-Award100,000$4.66
Jan 5, 2024Brady Stephen R · director, officer: President and CEOA-Award250,000$4.66
Jan 5, 2024Maestas Nicholas · officer: VP of Strategy and FinanceA-Award40,000$4.66
Jan 5, 2024Trojanowski Justin · officer: Principal Accounting OfficerA-Award26,500$4.66
Oct 13, 2023Brady Stephen R · director, officer: President and CEOA-Award725,000$9.77
Oct 13, 2023Maestas Nicholas · officer: VP of Strategy and FinanceA-Award100,000$9.77
Institutional positioning

13F filings over the trailing two quarters

New 6Increased 3Reduced 4Sold out 21
FilerActionSharesFiled
VANGUARD CAPITAL MANAGEMENT LLCNew Position233,888May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased86,990May 15, 2026
VANGUARD FIDUCIARY TRUST CONew Position68,908May 8, 2026
BLACKROCK, INC.Unchanged39,068May 13, 2026
FMR LLCUnchanged33,225May 15, 2026
CITADEL ADVISORS LLCNew Position19,820Sep 2, 2026
SABBY MANAGEMENT, LLCReduced17,856May 15, 2026
NORTHERN TRUST CORPUnchanged14,053May 14, 2026
DIMENSIONAL FUND ADVISORS LPUnchanged11,444May 7, 2026
UBS GROUP AGReduced4,533May 5, 2026
TOWER RESEARCH CAPITAL LLC (TRC)Increased2,790May 15, 2026
MORGAN STANLEYReduced2,058May 15, 2026
ADVISOR GROUP HOLDINGS, INC.Reduced1,529May 15, 2026
FEDERATION DES CAISSES DESJARDINS DU QUEBECUnchanged292May 14, 2026
JONES FINANCIAL COMPANIES LLLPUnchanged239May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 23, 2026